The Long-Term Functional and Oncologic Outcomes of Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma

被引:1
|
作者
Wang, Yu-Chieh [1 ,2 ]
Li, Jian-Ri [3 ,4 ,5 ]
Chen, Chuan-Shu [3 ,4 ,6 ]
Wang, Shian-Shiang [3 ,4 ,6 ,7 ]
Yang, Cheng-Kuang [3 ]
Chiu, Kun-Yuan [3 ,7 ]
Hsu, Chiann-Yi [8 ]
机构
[1] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan
[2] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Dept Urol, Dept Surg, Taichung, Taiwan
[4] Natl Chung Hsing Univ, Coll Med, Dept Postbaccalaureate Med, Taichung, Taiwan
[5] Hung Kuang Univ, Coll Nursing, Taichung, Taiwan
[6] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[7] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan
[8] Taichung Vet Gen Hosp, Dept Med Res, Biostat Grp, Taichung, Taiwan
关键词
Upper tract urothelial carcinoma; Transitional cell carcinoma; Nephroureterectomy; Organ-sparing treatment; Functional outcomes; Oncological outcomes; RADICAL NEPHROURETERECTOMY;
D O I
10.1245/s10434-024-16523-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThis study investigated the utilization of kidney-sparing surgery (KSS) as an alternative option to radical nephroureterectomy (RNU) in managing upper urinary tract urothelial carcinoma (UTUC) patients.ObjectiveOur study aimed to compare the functional outcomes and oncological outcomes between KSS and RNU.Material and MethodsWe retrospectively analyzed 252 patients with UTUC without clinical node positivity or metastasis who had been treated with either RNU or KSS. We collected information on each patient, including clinicopathological factors, renal function variations, and oncological outcomes. Hemodialysis-free survival (HDFS), stage 4 chronic kidney disease (CKD4) progression-free survival (PFS), recurrence-free survival (RFS), and overall survival (OS) were assessed using inverse probability of treatment weighting (IPTW)-weighted Kaplan-Meier analysis. The hazard ratio for oncological and functional outcomes of KSS was analyzed using the Cox proportional hazards model.ResultsThe OS at 8 years was 77.06% (RNU) and 70.59% (KSS) and did not significantly differ between the two groups (p = 0.691), although the KSS group experienced a higher recurrence rate. Functional outcomes indicated no significant difference in postoperative renal function at 1 year; however, KSS was associated with better preservation of renal function (23.44% vs. 28.23%), albeit not statistically significant (p = 0.055). Kaplan-Meier analysis revealed no significant disparities in CKD4 PFS between the KSS and RNU groups involved in the study (p = 0.089), although the KSS group displayed poorer HDFS than the RNU group (p = 0.001).ConclusionKSS had no compromising survival outcomes when compared with RNU, not only in low-risk patients but also in high-risk patients with a normal contralateral kidney. The efficacy of renal function preservation was presented in this study, however the results were below our expectations.
引用
收藏
页码:1354 / 1363
页数:10
相关论文
共 50 条
  • [1] ASO Visual Abstract: The Long-Term Functional and Oncologic Outcomes of Kidney-Sparing Surgery in Upper-Tract Urothelial Carcinoma
    Wang, Yu-Chieh
    Li, Jian-Ri
    Chen, Chuan-Shu
    Wang, Shian-Shiang
    Yang, Cheng-Kuang
    Chiu, Kun-Yuan
    Hsu, Chiann-Yi
    ANNALS OF SURGICAL ONCOLOGY, 2024, : 3232 - 3233
  • [2] Kidney-Sparing Surgery for Upper Tract Urothelial Carcinoma-Modalities, Outcomes, and Limitations
    Head, Dennis J.
    Raman, Jay D.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (21)
  • [3] Kidney-sparing surgery for upper tract urothelial cancer
    Lucca, Ilaria
    Klatte, Tobias
    Roupret, Morgan
    Shariat, Shahrokh F.
    CURRENT OPINION IN UROLOGY, 2015, 25 (02) : 100 - 104
  • [4] Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma
    Hendriks, Nora
    Baard, Joyce
    Beerlage, Harrie P.
    Schout, Barbara M. A.
    Doherty, Klara S. G.
    Pelger, Rob C. M.
    Kamphuis, Guido M.
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 40 : 104 - 111
  • [5] Modern Kidney-Sparing Management of Upper Tract Urothelial Carcinoma
    Ghoreifi, Alireza
    Sari Motlagh, Reza
    Fuchs, Gerhard
    CANCERS, 2023, 15 (18)
  • [6] ASO Author Reflections: The Impact of Kidney-Sparing Surgery in Upper Tract Urothelial Carcinoma
    Wang, Yu-Chieh
    Li, Jian-Ri
    Chen, Chuan-Shu
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (03) : 2245 - 2246
  • [7] Comparative outcomes of radical nephroureterectomy and kidney-sparing surgery in the treatment of high-grade upper tract urothelial carcinoma
    Moore, Kyle
    Gao, Helen
    Delgado, Jennifer
    Kulkarni, Anirudh
    Lichtbroun, Benjamin
    Chua, Kevin J.
    Pfail, John
    Srivastava, Arnav
    Packiam, Vignesh T.
    Golombos, David
    Jang, Thomas L.
    Ghodoussipour, Saum
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Comparative outcomes of radical nephroureterectomy and kidney-sparing surgery in the treatment of high-grade upper tract urothelial carcinoma
    Gao, Helen
    Moore, Kyle
    Delgado, Jennifer
    Kulkarni, Anirudh
    Lichtbroun, Benjamin
    Chua, Kevin J.
    Pfail, John
    Packiam, Vignesh T.
    Golombos, David
    Jang, Thomas L.
    Ghodoussipour, Saum
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 607 - 607
  • [9] Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art
    Territo, Angelo
    Foerster, Bear
    Shariat, Shahrokh F.
    Roupret, Morgan
    Gaya, Jose M.
    Palou, Joan
    Breda, Alberto
    MINERVA UROLOGICA E NEFROLOGICA, 2018, 70 (03) : 242 - +
  • [10] EFFECT OF DELAY TO NEPHROURETERECTOMY AFTER KIDNEY-SPARING TREATMENTS ON PATHOLOGIC AND SURVIVAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA
    Pak, Jamie S.
    Margolin, Ezra J.
    Lee, Kevin
    Anderson, Christopher B.
    JOURNAL OF UROLOGY, 2021, 206 : E866 - E866